MedPath

SANDOZ DEFERASIROX (TYPE J)

SANDOZ DEFERASIROX (TYPE J)

Approved
DIN Number

02489902

Drug Class

Human

Market Date

Apr 19, 2021

Company
HC

Sandoz Canada, Inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02489902
AIG Number0151733005
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
V03AC03 DEFERASIROX
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification64:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

DEFERASIROXActive
Strength: 180 MG
Monograph: DEFERASIROX

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.